Find out what makes Chinese technology move with us. We bring together what you need to know about the local business scene every Thursday morning at 8:00 a.m. (GMT +8), covering top investment stories, MNC partnerships, notable startups, industries with the most investments for the week, and more.

This is a preview of what you will receive in your inbox. Get the full picture by subscribing to China Venture Roundup.

Initial public offering: initial public offerings

On May 31, Xikang submitted its prospectus to the HKEX. Xikang is the first city-wide collaborative medical and health management platform in China.

Leveraging its proprietary cloud platform, Xikang provides SaaS tools to hospitals and clinics to adopt a centralized digital infrastructure, which integrates city health resources and enables information sharing between healthcare providers. primary health care, pharmacies and other health care operators. Thanks to the information hosted on the platform, patients can request consultations and prescriptions remotely.

At present, Xikang has partnered with more than 1,815 hospitals in 25 cities, making it the largest cloud-based home hospital network platform.

Startups on our watchlist

ChromX Health (精 智 未来)

Founded in 2021, ChromX Health develops smart breathalysers for clinical diagnostics. Through non-invasive testing, the company’s device enables rapid detection and early detection of various medical conditions.

To facilitate more application scenarios in hospitals, nursing homes and individual homes, ChromX Health recently released portable devices with smaller calibrated analyzers with high sensitivity and resolution. The company is currently working with leading hospitals in China and the United States to develop tests for cancer, infectious disease, and chronic disease.

KrASIE News

Chinese tech tycoons spur wave of philanthropy but efforts fail

Philanthropy is nothing new in the tech world, many people have wanted to give back as they build their careers and financial resources. Chinese tech moguls are no exception to these charitable efforts, with figures like Jack Ma of Alibaba, as well as Pony Ma and Charles Chen of Tencent making significant strides. Despite their well-intentioned businesses, the lack of change and lingering inequalities for workers nullify their philanthropy. How did the efforts of China’s new donor class come to fruition?